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AbstrAct:
Multiple primary melanomas are described in literature as a relatively rare, but nevertheless well 
known entity. The incidence varies from 0.2 to 23 % worldwide. Many risk factors for the devel-
opment of multiple primary melanomas have been observed, including multiple dysplastic nevi, 
positive family history, over 60 years of age at diagnosis of first melanoma, male sex and white race. 
The first primary melanoma in patients with multiple primary melanomas has the greatest tumour 
thickness, while subsequent melanomas are usually significantly less invasive, most probably due to 
strict follow-up schedules and regular self-examinations. We will report of two patients with multiple 
primary melanomas and follow-up methods for early detection of other primary melanomas. 
Keywords: melanoma, multiple primary melanoma, risk factors, dermoscopy, dysplastic nevus 
syndrome
Sažetak:
Multipli primarni melanomi se u literaturi navode kao relativno rijedak, ali dobro poznat entitet, a 
podaci o incidenciji variraju od 0,2 do 23% diljem svijeta. Mnogi čimbenici rizika razvoja multiplih 
primarnih melanoma se opisuju, uključujući pozitivna obiteljska anamneza, brojni displastični nevu-
si, prvi primarni melanom otkriven poslije 60. godine života, svijetla put i muški spol. Prvi je mela-
nom u većini slučajeva najveće debljine, dok su ostali melanomi značajno manje invazivni što se pov-
ezuje s redovitim praćenjem i samopregledima. Prikazat ćemo dva pacijenta s multiplim primarnim 
melanomima te metode praćenja tih bolesnika za rano otkrivanje novih primarnih melanoma. 




Nika Franceschi MD 
nika.franceschi@gmail.com 
orcid.org/0000-0002-7426-7547
This article was submitted to RAD 
CASA - Medical Sciences 
as the case report
Conflict of Interest Statement: 
The authors declare that the research 
was conducted in the absence of any 
commercial or financial relationships 
that could be construed as a potential 
conflict of interest.
Received: 10 June 2019
Accepted: 24 June 2019
Published: 22 July 2019
Citation:
Franceschi N, Buljan M and Situm M. 
Are multiple primary melanomas a 
rare entity? RAD CASA - Medical Sci-
ences. 537=46-47 (2019): 44-47
DOI: 10.21857/ypn4oc8jw9
Copyright (C) 2019 Franceschi, Buljan 
and Situm.This is an open-access 
article distributed under the terms 
of the Creative Commons Attribution 
License (CC BY). The use, distribution 
or reproduction in other forums is 
permitted, provided the original au-
thor(s) and the copyright owners(s) 
are credited and that the original 
publication in this journal is cited, in 
accordance whit accepted adacemic 
practice. No use, distribution or 
reproduction is permitted which does 
not comply with these terms. 
Case Report
RAD CASA - Medical Sciences   -   www.rad-med.com July 2019   -   Vol 537 = 46-4745
introduction
Multiple primary melanomas are described in the literature as a 
relatively rare, however well-known entity. Incidence varies from 
0.2 to 8.6% in Europe, while in populations with high melano-
ma incidence, such as Queensland, Australia, multiple primary 
melanoma incidence is as high as 23% 1,2. Multiple primary 
melanomas were first described in the literature by Pack and 
colleagues in 1952 3, and the highest number of primary mela-
nomas observed in one patient is 48 4. Patients with a personal 
history of melanoma have a 9 to 25 times higher risk of devel-
oping another melanoma than the risk of developing melanoma 
in the general population5. People with multiple dysplastic nevi 
and/or positive family history have the highest risk of developing 
multiple primary melanomas 6-9. Additionally, more than 60 
years of age at diagnosis of first melanoma, male sex and white 
race have also been observed as risk factors10. As much as 18 to 
36% of multiple primary melanoma patients have a positive 
family history for melanoma, while 38 to 46% of patients with 
multiple primary melanomas have dysplastic nevi6,11,12. 
The risk of developing a second primary melanoma is greatest 
within the first year, however, remains increased for more than 
20 years after the first primary melanoma diagnosis 7,13-15. In 
patients with multiple primary melanoma the first melanoma has 
the greatest tumor thickness, while subsequent melanomas are 
usually significantly less invasive. Ferrone and colleagues reported 
in situ melanoma accounting for 21% of first primary melano-
mas, 50% of second, 55% of third and 70% of fourth primary 
melanomas, confirming the observation that in situ melanoma 
diagnosis is more frequent in subsequent melanomas 5,7,10,16-19. 
Lower incidence of vertical growth phase and nodular histotype 
have also been reported in invasive subsequent melanomas7,16. 
These observations are most probably associated with strict 
follow-up schedules and regular self-examinations, and therefore 
earlier detection of new melanomas. Less aggressive tumor biol-
ogy and development of sinecomitant immunity have also been 
previously suggested7,20. However, unlike earlier research results, 
several recent studies have shown that patients with multiple 
primary melanomas have a poorer survival compared to patients 
with a single primary melanoma10,21,22.
caSe reportS
An 84-year-old male patient with dysplastic nevus syndrome 
(Figure 1, 2) had a nodular melanoma Breslow thickness of 2 
mm removed from the left side of the chest in 1996. Since then, 
he has had more than 30 new primary melanomas (3 lentigo ma-
ligna melanoma, 1 nodular melanoma, 21 superficial spreading 
melanomas (the thickest being 0.49 mm), 9 melanomas in situ) 
removed up to date. The most recent melanoma was found on 
the palpebral conjunctiva, 3.15 mm thick. The patient had also 
had a basal cell carcinoma, SAMPUS (superficial atypical mela-
nocytic proliferations of uncertain significance) lesion, and many 
dysplastic nevi removed. Patient history revealed the patient 
had worked in a paint factory for many years, and had several 
blistering sunburns when younger. Family history is positive for 
melanoma, three sisters and a brother also had melanoma, while 
his father died of leukemia. Gene mutation analysis performed in 
2011 of the p16 gene (melanoma susceptibility gene) was nega-
tive. The patient was regularly monitored every six months (since 
the removal of melanoma of the palpabra once more every three 
months) and his evaluation included  dermatologic and oph-
thalmologic examination, LDH, S100B, basic laboratory tests, 
ultrasonography of regional lymph nodes, postoperative scars, 
and when necessary, excision of atypical lesions on the skin.
A 45-year-old male patient is regularly monitored due to 
melanoma excised from the chest four years ago (Cl III, Br II, 
Breslow thickness of 0.9 mm). Given the patient has dysplastic 
Figure 1. and Figure 2. 84-year-old male patient with dysplastic nevus syndrome and 
history of multiple primary melanomas 
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nevus syndrome (Figure 3), apart from regular dermatologic 
examination, the patient is also monitored with digital dermos-
copy (total-body photography and sequential digital dermos-
copy imaging) and, when necessary excision of atypical lesions 
is performed. Four years after the first primary melanoma was 
removed, a newly discovered dark pigmented macula of about 
5 mm in size was observed at the upper edge of a congenital 
nevus located on the skin in the right supraclavicular area during 
digital total-body photography follow-up (Figure 4). The lesion 
was excised and histopathological analysis confirmed a second 
primary melanoma; superficial spreading melanoma (Cl II, Br I, 
0.38 mm thick).
diScuSSion
Follow-up of patients with multiple primary melanomas does 
not differ from follow-up of patients with a single primary mel-
anoma. Patients are monitored according to current guidelines, 
and thickness of the most invasive melanoma. The most signifi-
cant methods of monitoring these patients are regular full-body 
dermatologic examinations (including scalp, genital area, oral 
mucous membrane and nail examination) with digital dermos-
copy follow-up (total body photography and sequential digital 
dermoscopy imaging), as well as ophthalmologic and gynecologic 
examination when necessary. 
Digital dermoscopy helps record the dynamic changes of pig-
mented skin lesions. Therefore, discrete morphological chang-
es in existing or newly diagnosed lesions observed in digital 
dermoscopy, for example asymmetric growth of a nevus, may 
indicate development of melanoma despite the absence of other 
specific dermoscopic and clinical criteria for melanoma23. Salerni 
and colleagues carried out a meta-analysis of 14 studies (5787 
patients) investigating the impact of digital dermoscopy on the 
monitoring of melanocytic lesions in people with increased risk 
for melanoma development. Results of the study showed that 
digital dermoscopy follow-up significantly increased the detec-
tion of early melanoma in high-risk patients, thus reducing the 
number of unnecessary excisions of benign lesions24.
In addition to carrying out diagnostic procedures according to 
guidelines, it is extremely important to educate multiple primary 
melanoma patients about the significance of regular skin self-ex-
aminations, use of sun-protective measures and dermatologic 
examination of other family members25,26.
concluSion
Although multiple primary melanomas are referred to as a 
relatively rare entity in the literature, we believe the number 
of patients with multiple primary melanomas is higher than 
previously recognized. All patients diagnosed with a primary 
melanoma have a high risk of developing a second or more 
primary melanomas, therefore regular dermatologic follow-up 
with a thorough examination of the skin and visible mucous 
membranes is essential. For individuals with a large number 
of atypical nevi and history of melanoma, the most effective 
method for early detection of other primary melanomas is digital 
dermoscopy follow-up – total-body photography and sequential 
digital dermoscopy imaging. This enables detection of melanoma 
at the earliest stage, prior to the development of classic dermo-
scopic and clinical characteristics of melanoma.
Figure 3. 45-year-old male patient with dysplastic nevus syndrome
Figure 4. Four years after the first primary melanoma was removed, a newly discov-
ered dark pigmented macula of about 5 mm in size was observed at the upper edge of 
a congenital nevus located on the skin in the right supraclavicular area during digital 
total-body photography follow-up
Case Report
RAD CASA - Medical Sciences   -   www.rad-med.com July 2019   -   Vol 537 = 46-4747
author contributionS:
All authors listed have made a substantial, direct and intellectual 
contribution to the work, and approved it for publication.
literature:
1. Savoia P, Osella-Abate S, Deboli T, et al. Clinical and prognos-
tic reports from 270 patients with multiple primary melanomas: 
a 34-year single-institution study.  J Eur Acad Dermatol Venereol. 
2012;26(7):882-8. doi: 10.1111/j.1468-3083.2011.04181.x.
2. Youlden DR, Youl PH, Soyer HP, Aitken JF, Baade PD. Distribution 
of subsequent primary invasive melanomas following a first primary 
invasive or in situ melanoma Queensland, Australia, 1982-2010. JAMA 
Dermatol. 2014;150(5):526-34.
3. Pack GT, Scharnagel IM, Hillyer RA. Multiple primary melanoma. 
Cancer. 1952;5(6):1110-5.
4. Slingluff CL Jr, Vollmer RT, Seigler HF. Multiple primary melanoma: 
: incidence and risk factors in 283 patients. Surgery. 1993;113(3):330-9.
5. Vecchiato A, Pasquali S, Menin C, et al. Histopathological charac-
teristics of subsequent melanomas in patients with multiple primary 
melanomas. J Eur Acad Dermatol Venereol. 2014;28(1):58-64. doi: 
10.1111/jdv.12055.
6. Blackwood MA, Holmes R, Synnestvedt M, et al. Multiple primary 
melanoma revisited. Cancer. 2002;94(8):2248-55.
7. Ferrone CR, Ben Porat L, Panageas KS, et al. Clinicopathological 
features of and risk factors for multiple primary melanomas. JAMA. 
2005;294(13):1647-54.
8. Titus-Ernstoff L, Duray PH, Ernstoff MS, Barnhill RL, Horn PL, 
Kirkwood JM. Dysplastic nevi in association with multiple primary 
melanoma. Cancer Res. 1988;48(4):1016-8.
9. Titus-Ernstoff L, Perry AE, Spencer SK, et al. Multiple primary mel-
anoma: 2-year results from a population-based study. Arch Dermatol. 
2006;142:433-8.
10. Nosrati A, Yu WY, McGuire J, et al. Outcomes and Risk Factors 
in Patients with Multiple Primary Melanomas. J Invest Dermatol. 
2019;139(1):195-201. doi: 10.1016/j.jid.2018.07.009.
11. Giles G, Staples M, McCredie M, Coates M. Multiple primary 
melanomas: an analysis of cancer registry data from Victoria and New 
South Wales. Melanoma Res. 1995;5(6):433-8.
12. DiFronzo LA, Wanek LA, Elashoff R, Morton DL. Increased 
incidence of second primary melanoma in patients with a previous 
cutaneous melanoma. Ann Surg Oncol. 1999;6(7):705-11.
13. Goggins WB, Tsao H. A population-based analysis of risk factors 
for a second primary cutaneous melanoma among melanoma survivors. 
Cancer. 2003;97(3):639-43.
14. van der Leest RJ, Liu L, Coebergh JW, et al. Risk of second primary 
in situ and invasive melanoma in a Dutch population-based cohort: 
1989-2008. Br J Dermatol. 2012;167(6):1321-30. doi: 10.1111/j.1365-
2133.2012.11123.x.
15. Bradford PT, Freedman DM, Goldstein AM, Tucker MA. Increased 
risk of second primary cancers after a diagnosis of melanoma. Arch 
Dermatol. 2010;146(3):265-72. doi: 10.1001/archdermatol.2010.2.
16. Murali R, Goumas C, Kricker A, et al. Clinicopathologic features 
of incident and subsequent tumors in patients with multiple primary 
cutaneous melanomas. Ann Surg Oncol. 2012;19(3):1024-33. doi: 
10.1245/s10434-011-2058-8.
17. Uliasz A, Lebwohl M. Patient education and regular surveillance 
results in earlier diagnosis of second primary melanoma. Int J Dermatol. 
2007;46(6):575-7.
18. Moore MM, Geller AC, Warton EM, Schwalbe J, Asgari MM. Mul-
tiple primary melanomas among 16,570 patients with melanoma diag-
nosed at Kaiser Permanente Northern California, 1996 to 2011. J Am 
Acad Dermatol. 2015;73(4):630-6. doi: 10.1016/j.jaad.2015.06.059.
19. Menzies S, Barry R, Ormond P. Multiple primary melanoma: a 
single centre retrospective review. Melanoma Res. 2017;27(6):638-40. 
doi: 10.1097/CMR.0000000000000395.
20. Doubrovsky A, Menzies SW. Enhanced survival in patients with 
multi-ple primary melanoma. Arch Dermatol. 2003;139(8):1013-8.
21. Pardo LM, van der Leest RJ, de Vries E, Soerjomataram I, Nijsten T, 
Hollestein LM. Comparing survival of patients with single or multiple 
primary melanoma in the Netherlands: 1994-2009. Br J Dermatol. 
2017;176(2):531-3. doi: 10.1111/bjd.14846.
22. Youlden DR, Baade PD, Soyer HP. Ten-Year Survival after Multiple 
Invasive Melanomas Is Worse than after a Single Melanoma: a Pop-
ulation-Based Study. J Invest Dermatol. 2016;136(11):2270-6. doi: 
10.1016/j.jid.2016.03.014
23. Salerni G, Carrera C, Lovatto L, et al. Characterization of 1152 
lesions excised over 10 years using total-body photography and digital 
dermatoscopy in the surveillance of patients at high risk for mela-
noma. J Am Acad Dermatol. 2012;67(5):836-45. doi: 10.1016/j.
jaad.2012.01.028.
24. Salerni G, Terán T, Puig S, et al. Meta-analysis of digital dermos-
copy follow-up of melanocytic skin lesions: a study on behalf of the 
International Dermoscopy Society. J Eur Acad Dermatol Venereol. 
2013;27(7):805-14. doi: 10.1111/jdv.12032.
25. Buljan M, Tomić Sremec N, Sremec J, Tomas D, Crnaric I, Šitum 
M. Disease Progression in Cases of Multiple Primary Melanoma. Acta 
Dermatovenerol Croat. 2015;23(4):260-4.
26. Manganoni AM, Farisoglio C, Tucci G, Facchetti F, Calzavara Pin-
ton PG. The importance of self- examination in the earliest diagnosis of 
multiple primary cutaneous melanomas: a report of 47 cases. J Eur Acad 
Dermatol Venereol. 2007;21(10):1333-6.
Case Report
